Spaces:
Sleeping
Sleeping
| Dataset Group Value Variable | |
| lymphoma TNFA SIGNALING VIA NFKB 0.46 Proportion of DE Features | |
| lymphoma HYPOXIA 0.37 Proportion of DE Features | |
| lymphoma CHOLESTEROL HOMEOSTASIS 0.56 Proportion of DE Features | |
| lymphoma MITOTIC SPINDLE 0.74 Proportion of DE Features | |
| lymphoma WNT BETA CATENIN SIGNALING 0.4883720930232558 Proportion of DE Features | |
| lymphoma TGF BETA SIGNALING 0.6181818181818182 Proportion of DE Features | |
| lymphoma IL6 JAK STAT3 SIGNALING 0.5 Proportion of DE Features | |
| lymphoma DNA REPAIR 0.7483443708609272 Proportion of DE Features | |
| lymphoma G2M CHECKPOINT 0.76 Proportion of DE Features | |
| lymphoma APOPTOSIS 0.49382716049382713 Proportion of DE Features | |
| lymphoma NOTCH SIGNALING 0.48484848484848486 Proportion of DE Features | |
| lymphoma ADIPOGENESIS 0.58 Proportion of DE Features | |
| lymphoma ESTROGEN RESPONSE EARLY 0.405 Proportion of DE Features | |
| lymphoma ESTROGEN RESPONSE LATE 0.35 Proportion of DE Features | |
| lymphoma ANDROGEN RESPONSE 0.6372549019607843 Proportion of DE Features | |
| lymphoma MYOGENESIS 0.245 Proportion of DE Features | |
| lymphoma PROTEIN SECRETION 0.8350515463917526 Proportion of DE Features | |
| lymphoma INTERFERON ALPHA RESPONSE 0.6122448979591837 Proportion of DE Features | |
| lymphoma INTERFERON GAMMA RESPONSE 0.65 Proportion of DE Features | |
| lymphoma APICAL JUNCTION 0.38 Proportion of DE Features | |
| lymphoma APICAL SURFACE 0.37777777777777777 Proportion of DE Features | |
| lymphoma HEDGEHOG SIGNALING 0.3783783783783784 Proportion of DE Features | |
| lymphoma COMPLEMENT 0.535 Proportion of DE Features | |
| lymphoma UNFOLDED PROTEIN RESPONSE 0.7280701754385965 Proportion of DE Features | |
| lymphoma PI3K AKT MTOR SIGNALING 0.7547169811320755 Proportion of DE Features | |
| lymphoma MTORC1 SIGNALING 0.755 Proportion of DE Features | |
| lymphoma E2F TARGETS 0.745 Proportion of DE Features | |
| lymphoma MYC TARGETS V1 0.875 Proportion of DE Features | |
| lymphoma MYC TARGETS V2 0.7627118644067796 Proportion of DE Features | |
| lymphoma EPITHELIAL MESENCHYMAL TRANSITION 0.2 Proportion of DE Features | |
| lymphoma INFLAMMATORY RESPONSE 0.39 Proportion of DE Features | |
| lymphoma XENOBIOTIC METABOLISM 0.35 Proportion of DE Features | |
| lymphoma FATTY ACID METABOLISM 0.559748427672956 Proportion of DE Features | |
| lymphoma OXIDATIVE PHOSPHORYLATION 0.83 Proportion of DE Features | |
| lymphoma GLYCOLYSIS 0.495 Proportion of DE Features | |
| lymphoma REACTIVE OXYGEN SPECIES PATHWAY 0.7 Proportion of DE Features | |
| lymphoma P53 PATHWAY 0.52 Proportion of DE Features | |
| lymphoma UV RESPONSE UP 0.4528301886792453 Proportion of DE Features | |
| lymphoma UV RESPONSE DN 0.5310344827586206 Proportion of DE Features | |
| lymphoma ANGIOGENESIS 0.10810810810810811 Proportion of DE Features | |
| lymphoma HEME METABOLISM 0.54 Proportion of DE Features | |
| lymphoma COAGULATION 0.2302158273381295 Proportion of DE Features | |
| lymphoma IL2 STAT5 SIGNALING 0.535 Proportion of DE Features | |
| lymphoma BILE ACID METABOLISM 0.4336283185840708 Proportion of DE Features | |
| lymphoma PEROXISOME 0.638095238095238 Proportion of DE Features | |
| lymphoma ALLOGRAFT REJECTION 0.64 Proportion of DE Features | |
| lymphoma SPERMATOGENESIS 0.3014705882352941 Proportion of DE Features | |
| lymphoma KRAS SIGNALING UP 0.4 Proportion of DE Features | |
| lymphoma KRAS SIGNALING DN 0.235 Proportion of DE Features | |
| lymphoma PANCREAS BETA CELLS 0.1951219512195122 Proportion of DE Features | |
| LUSC TNFA SIGNALING VIA NFKB 0.695 Proportion of DE Features | |
| LUSC HYPOXIA 0.48 Proportion of DE Features | |
| LUSC CHOLESTEROL HOMEOSTASIS 0.52 Proportion of DE Features | |
| LUSC MITOTIC SPINDLE 0.305 Proportion of DE Features | |
| LUSC WNT BETA CATENIN SIGNALING 0.32558139534883723 Proportion of DE Features | |
| LUSC TGF BETA SIGNALING 0.41818181818181815 Proportion of DE Features | |
| LUSC IL6 JAK STAT3 SIGNALING 0.5113636363636364 Proportion of DE Features | |
| LUSC DNA REPAIR 0.3708609271523179 Proportion of DE Features | |
| LUSC G2M CHECKPOINT 0.325 Proportion of DE Features | |
| LUSC APOPTOSIS 0.47530864197530864 Proportion of DE Features | |
| LUSC NOTCH SIGNALING 0.3333333333333333 Proportion of DE Features | |
| LUSC ADIPOGENESIS 0.405 Proportion of DE Features | |
| LUSC ESTROGEN RESPONSE EARLY 0.395 Proportion of DE Features | |
| LUSC ESTROGEN RESPONSE LATE 0.435 Proportion of DE Features | |
| LUSC ANDROGEN RESPONSE 0.46078431372549017 Proportion of DE Features | |
| LUSC MYOGENESIS 0.25 Proportion of DE Features | |
| LUSC PROTEIN SECRETION 0.3711340206185567 Proportion of DE Features | |
| LUSC INTERFERON ALPHA RESPONSE 0.41836734693877553 Proportion of DE Features | |
| LUSC INTERFERON GAMMA RESPONSE 0.515 Proportion of DE Features | |
| LUSC APICAL JUNCTION 0.365 Proportion of DE Features | |
| LUSC APICAL SURFACE 0.37777777777777777 Proportion of DE Features | |
| LUSC HEDGEHOG SIGNALING 0.24324324324324326 Proportion of DE Features | |
| LUSC COMPLEMENT 0.47 Proportion of DE Features | |
| LUSC UNFOLDED PROTEIN RESPONSE 0.45614035087719296 Proportion of DE Features | |
| LUSC PI3K AKT MTOR SIGNALING 0.4339622641509434 Proportion of DE Features | |
| LUSC MTORC1 SIGNALING 0.635 Proportion of DE Features | |
| LUSC E2F TARGETS 0.365 Proportion of DE Features | |
| LUSC MYC TARGETS V1 0.715 Proportion of DE Features | |
| LUSC MYC TARGETS V2 0.4915254237288136 Proportion of DE Features | |
| LUSC EPITHELIAL MESENCHYMAL TRANSITION 0.395 Proportion of DE Features | |
| LUSC INFLAMMATORY RESPONSE 0.5 Proportion of DE Features | |
| LUSC XENOBIOTIC METABOLISM 0.405 Proportion of DE Features | |
| LUSC FATTY ACID METABOLISM 0.4339622641509434 Proportion of DE Features | |
| LUSC OXIDATIVE PHOSPHORYLATION 0.545 Proportion of DE Features | |
| LUSC GLYCOLYSIS 0.41 Proportion of DE Features | |
| LUSC REACTIVE OXYGEN SPECIES PATHWAY 0.6 Proportion of DE Features | |
| LUSC P53 PATHWAY 0.445 Proportion of DE Features | |
| LUSC UV RESPONSE UP 0.4025157232704403 Proportion of DE Features | |
| LUSC UV RESPONSE DN 0.3448275862068966 Proportion of DE Features | |
| LUSC ANGIOGENESIS 0.4864864864864865 Proportion of DE Features | |
| LUSC HEME METABOLISM 0.325 Proportion of DE Features | |
| LUSC COAGULATION 0.302158273381295 Proportion of DE Features | |
| LUSC IL2 STAT5 SIGNALING 0.46 Proportion of DE Features | |
| LUSC BILE ACID METABOLISM 0.18584070796460178 Proportion of DE Features | |
| LUSC PEROXISOME 0.3047619047619048 Proportion of DE Features | |
| LUSC ALLOGRAFT REJECTION 0.545 Proportion of DE Features | |
| LUSC SPERMATOGENESIS 0.13970588235294118 Proportion of DE Features | |
| LUSC KRAS SIGNALING UP 0.41 Proportion of DE Features | |
| LUSC KRAS SIGNALING DN 0.11 Proportion of DE Features | |
| LUSC PANCREAS BETA CELLS 0.12195121951219512 Proportion of DE Features | |
| LUAD TNFA SIGNALING VIA NFKB 0.715 Proportion of DE Features | |
| LUAD HYPOXIA 0.595 Proportion of DE Features | |
| LUAD CHOLESTEROL HOMEOSTASIS 0.72 Proportion of DE Features | |
| LUAD MITOTIC SPINDLE 0.53 Proportion of DE Features | |
| LUAD WNT BETA CATENIN SIGNALING 0.5116279069767442 Proportion of DE Features | |
| LUAD TGF BETA SIGNALING 0.7272727272727273 Proportion of DE Features | |
| LUAD IL6 JAK STAT3 SIGNALING 0.5227272727272727 Proportion of DE Features | |
| LUAD DNA REPAIR 0.6423841059602649 Proportion of DE Features | |
| LUAD G2M CHECKPOINT 0.39 Proportion of DE Features | |
| LUAD APOPTOSIS 0.6172839506172839 Proportion of DE Features | |
| LUAD NOTCH SIGNALING 0.5757575757575758 Proportion of DE Features | |
| LUAD ADIPOGENESIS 0.735 Proportion of DE Features | |
| LUAD ESTROGEN RESPONSE EARLY 0.655 Proportion of DE Features | |
| LUAD ESTROGEN RESPONSE LATE 0.64 Proportion of DE Features | |
| LUAD ANDROGEN RESPONSE 0.6862745098039216 Proportion of DE Features | |
| LUAD MYOGENESIS 0.385 Proportion of DE Features | |
| LUAD PROTEIN SECRETION 0.8041237113402062 Proportion of DE Features | |
| LUAD INTERFERON ALPHA RESPONSE 0.5510204081632653 Proportion of DE Features | |
| LUAD INTERFERON GAMMA RESPONSE 0.57 Proportion of DE Features | |
| LUAD APICAL JUNCTION 0.55 Proportion of DE Features | |
| LUAD APICAL SURFACE 0.4666666666666667 Proportion of DE Features | |
| LUAD HEDGEHOG SIGNALING 0.43243243243243246 Proportion of DE Features | |
| LUAD COMPLEMENT 0.595 Proportion of DE Features | |
| LUAD UNFOLDED PROTEIN RESPONSE 0.6754385964912281 Proportion of DE Features | |
| LUAD PI3K AKT MTOR SIGNALING 0.5754716981132075 Proportion of DE Features | |
| LUAD MTORC1 SIGNALING 0.75 Proportion of DE Features | |
| LUAD E2F TARGETS 0.41 Proportion of DE Features | |
| LUAD MYC TARGETS V1 0.81 Proportion of DE Features | |
| LUAD MYC TARGETS V2 0.4915254237288136 Proportion of DE Features | |
| LUAD EPITHELIAL MESENCHYMAL TRANSITION 0.49 Proportion of DE Features | |
| LUAD INFLAMMATORY RESPONSE 0.555 Proportion of DE Features | |
| LUAD XENOBIOTIC METABOLISM 0.56 Proportion of DE Features | |
| LUAD FATTY ACID METABOLISM 0.6289308176100629 Proportion of DE Features | |
| LUAD OXIDATIVE PHOSPHORYLATION 0.775 Proportion of DE Features | |
| LUAD GLYCOLYSIS 0.595 Proportion of DE Features | |
| LUAD REACTIVE OXYGEN SPECIES PATHWAY 0.78 Proportion of DE Features | |
| LUAD P53 PATHWAY 0.665 Proportion of DE Features | |
| LUAD UV RESPONSE UP 0.5911949685534591 Proportion of DE Features | |
| LUAD UV RESPONSE DN 0.503448275862069 Proportion of DE Features | |
| LUAD ANGIOGENESIS 0.4594594594594595 Proportion of DE Features | |
| LUAD HEME METABOLISM 0.525 Proportion of DE Features | |
| LUAD COAGULATION 0.5611510791366906 Proportion of DE Features | |
| LUAD IL2 STAT5 SIGNALING 0.66 Proportion of DE Features | |
| LUAD BILE ACID METABOLISM 0.415929203539823 Proportion of DE Features | |
| LUAD PEROXISOME 0.5428571428571428 Proportion of DE Features | |
| LUAD ALLOGRAFT REJECTION 0.535 Proportion of DE Features | |
| LUAD SPERMATOGENESIS 0.19852941176470587 Proportion of DE Features | |
| LUAD KRAS SIGNALING UP 0.575 Proportion of DE Features | |
| LUAD KRAS SIGNALING DN 0.215 Proportion of DE Features | |
| LUAD PANCREAS BETA CELLS 0.2926829268292683 Proportion of DE Features | |
| T47D TNFA SIGNALING VIA NFKB 0.325 Proportion of DE Features | |
| T47D HYPOXIA 0.355 Proportion of DE Features | |
| T47D CHOLESTEROL HOMEOSTASIS 0.38666666666666666 Proportion of DE Features | |
| T47D MITOTIC SPINDLE 0.58 Proportion of DE Features | |
| T47D WNT BETA CATENIN SIGNALING 0.27906976744186046 Proportion of DE Features | |
| T47D TGF BETA SIGNALING 0.4727272727272727 Proportion of DE Features | |
| T47D IL6 JAK STAT3 SIGNALING 0.2159090909090909 Proportion of DE Features | |
| T47D DNA REPAIR 0.4105960264900662 Proportion of DE Features | |
| T47D G2M CHECKPOINT 0.795 Proportion of DE Features | |
| T47D APOPTOSIS 0.35802469135802467 Proportion of DE Features | |
| T47D NOTCH SIGNALING 0.36363636363636365 Proportion of DE Features | |
| T47D ADIPOGENESIS 0.3 Proportion of DE Features | |
| T47D ESTROGEN RESPONSE EARLY 0.61 Proportion of DE Features | |
| T47D ESTROGEN RESPONSE LATE 0.55 Proportion of DE Features | |
| T47D ANDROGEN RESPONSE 0.4215686274509804 Proportion of DE Features | |
| T47D MYOGENESIS 0.23 Proportion of DE Features | |
| T47D PROTEIN SECRETION 0.4536082474226804 Proportion of DE Features | |
| T47D INTERFERON ALPHA RESPONSE 0.4897959183673469 Proportion of DE Features | |
| T47D INTERFERON GAMMA RESPONSE 0.405 Proportion of DE Features | |
| T47D APICAL JUNCTION 0.285 Proportion of DE Features | |
| T47D APICAL SURFACE 0.24444444444444444 Proportion of DE Features | |
| T47D HEDGEHOG SIGNALING 0.32432432432432434 Proportion of DE Features | |
| T47D COMPLEMENT 0.22 Proportion of DE Features | |
| T47D UNFOLDED PROTEIN RESPONSE 0.47368421052631576 Proportion of DE Features | |
| T47D PI3K AKT MTOR SIGNALING 0.37735849056603776 Proportion of DE Features | |
| T47D MTORC1 SIGNALING 0.56 Proportion of DE Features | |
| T47D E2F TARGETS 0.795 Proportion of DE Features | |
| T47D MYC TARGETS V1 0.745 Proportion of DE Features | |
| T47D MYC TARGETS V2 0.576271186440678 Proportion of DE Features | |
| T47D EPITHELIAL MESENCHYMAL TRANSITION 0.245 Proportion of DE Features | |
| T47D INFLAMMATORY RESPONSE 0.2 Proportion of DE Features | |
| T47D XENOBIOTIC METABOLISM 0.24 Proportion of DE Features | |
| T47D FATTY ACID METABOLISM 0.29559748427672955 Proportion of DE Features | |
| T47D OXIDATIVE PHOSPHORYLATION 0.345 Proportion of DE Features | |
| T47D GLYCOLYSIS 0.335 Proportion of DE Features | |
| T47D REACTIVE OXYGEN SPECIES PATHWAY 0.3 Proportion of DE Features | |
| T47D P53 PATHWAY 0.405 Proportion of DE Features | |
| T47D UV RESPONSE UP 0.3018867924528302 Proportion of DE Features | |
| T47D UV RESPONSE DN 0.4482758620689655 Proportion of DE Features | |
| T47D ANGIOGENESIS 0.21621621621621623 Proportion of DE Features | |
| T47D HEME METABOLISM 0.34 Proportion of DE Features | |
| T47D COAGULATION 0.14388489208633093 Proportion of DE Features | |
| T47D IL2 STAT5 SIGNALING 0.31 Proportion of DE Features | |
| T47D BILE ACID METABOLISM 0.23893805309734514 Proportion of DE Features | |
| T47D PEROXISOME 0.4 Proportion of DE Features | |
| T47D ALLOGRAFT REJECTION 0.21 Proportion of DE Features | |
| T47D SPERMATOGENESIS 0.22794117647058823 Proportion of DE Features | |
| T47D KRAS SIGNALING UP 0.14 Proportion of DE Features | |
| T47D KRAS SIGNALING DN 0.11 Proportion of DE Features | |
| T47D PANCREAS BETA CELLS 0.14634146341463414 Proportion of DE Features | |
| prostate_rna TNFA SIGNALING VIA NFKB 0.51 Proportion of DE Features | |
| prostate_rna HYPOXIA 0.5 Proportion of DE Features | |
| prostate_rna CHOLESTEROL HOMEOSTASIS 0.5733333333333334 Proportion of DE Features | |
| prostate_rna MITOTIC SPINDLE 0.41 Proportion of DE Features | |
| prostate_rna WNT BETA CATENIN SIGNALING 0.4186046511627907 Proportion of DE Features | |
| prostate_rna TGF BETA SIGNALING 0.6181818181818182 Proportion of DE Features | |
| prostate_rna IL6 JAK STAT3 SIGNALING 0.375 Proportion of DE Features | |
| prostate_rna DNA REPAIR 0.37748344370860926 Proportion of DE Features | |
| prostate_rna G2M CHECKPOINT 0.28 Proportion of DE Features | |
| prostate_rna APOPTOSIS 0.5555555555555556 Proportion of DE Features | |
| prostate_rna NOTCH SIGNALING 0.45454545454545453 Proportion of DE Features | |
| prostate_rna ADIPOGENESIS 0.425 Proportion of DE Features | |
| prostate_rna ESTROGEN RESPONSE EARLY 0.5 Proportion of DE Features | |
| prostate_rna ESTROGEN RESPONSE LATE 0.435 Proportion of DE Features | |
| prostate_rna ANDROGEN RESPONSE 0.696078431372549 Proportion of DE Features | |
| prostate_rna MYOGENESIS 0.29 Proportion of DE Features | |
| prostate_rna PROTEIN SECRETION 0.6701030927835051 Proportion of DE Features | |
| prostate_rna INTERFERON ALPHA RESPONSE 0.5306122448979592 Proportion of DE Features | |
| prostate_rna INTERFERON GAMMA RESPONSE 0.46 Proportion of DE Features | |
| prostate_rna APICAL JUNCTION 0.445 Proportion of DE Features | |
| prostate_rna APICAL SURFACE 0.4444444444444444 Proportion of DE Features | |
| prostate_rna HEDGEHOG SIGNALING 0.32432432432432434 Proportion of DE Features | |
| prostate_rna COMPLEMENT 0.415 Proportion of DE Features | |
| prostate_rna UNFOLDED PROTEIN RESPONSE 0.40350877192982454 Proportion of DE Features | |
| prostate_rna PI3K AKT MTOR SIGNALING 0.37735849056603776 Proportion of DE Features | |
| prostate_rna MTORC1 SIGNALING 0.48 Proportion of DE Features | |
| prostate_rna E2F TARGETS 0.275 Proportion of DE Features | |
| prostate_rna MYC TARGETS V1 0.41 Proportion of DE Features | |
| prostate_rna MYC TARGETS V2 0.2033898305084746 Proportion of DE Features | |
| prostate_rna EPITHELIAL MESENCHYMAL TRANSITION 0.345 Proportion of DE Features | |
| prostate_rna INFLAMMATORY RESPONSE 0.34 Proportion of DE Features | |
| prostate_rna XENOBIOTIC METABOLISM 0.365 Proportion of DE Features | |
| prostate_rna FATTY ACID METABOLISM 0.389937106918239 Proportion of DE Features | |
| prostate_rna OXIDATIVE PHOSPHORYLATION 0.42 Proportion of DE Features | |
| prostate_rna GLYCOLYSIS 0.4 Proportion of DE Features | |
| prostate_rna REACTIVE OXYGEN SPECIES PATHWAY 0.48 Proportion of DE Features | |
| prostate_rna P53 PATHWAY 0.53 Proportion of DE Features | |
| prostate_rna UV RESPONSE UP 0.41509433962264153 Proportion of DE Features | |
| prostate_rna UV RESPONSE DN 0.46206896551724136 Proportion of DE Features | |
| prostate_rna ANGIOGENESIS 0.2972972972972973 Proportion of DE Features | |
| prostate_rna HEME METABOLISM 0.41 Proportion of DE Features | |
| prostate_rna COAGULATION 0.35251798561151076 Proportion of DE Features | |
| prostate_rna IL2 STAT5 SIGNALING 0.395 Proportion of DE Features | |
| prostate_rna BILE ACID METABOLISM 0.3274336283185841 Proportion of DE Features | |
| prostate_rna PEROXISOME 0.4666666666666667 Proportion of DE Features | |
| prostate_rna ALLOGRAFT REJECTION 0.26 Proportion of DE Features | |
| prostate_rna SPERMATOGENESIS 0.16176470588235295 Proportion of DE Features | |
| prostate_rna KRAS SIGNALING UP 0.33 Proportion of DE Features | |
| prostate_rna KRAS SIGNALING DN 0.155 Proportion of DE Features | |
| prostate_rna PANCREAS BETA CELLS 0.12195121951219512 Proportion of DE Features | |
| MCF7 TNFA SIGNALING VIA NFKB 0.27 Proportion of DE Features | |
| MCF7 HYPOXIA 0.295 Proportion of DE Features | |
| MCF7 CHOLESTEROL HOMEOSTASIS 0.48 Proportion of DE Features | |
| MCF7 MITOTIC SPINDLE 0.63 Proportion of DE Features | |
| MCF7 WNT BETA CATENIN SIGNALING 0.32558139534883723 Proportion of DE Features | |
| MCF7 TGF BETA SIGNALING 0.5454545454545454 Proportion of DE Features | |
| MCF7 IL6 JAK STAT3 SIGNALING 0.22727272727272727 Proportion of DE Features | |
| MCF7 DNA REPAIR 0.39072847682119205 Proportion of DE Features | |
| MCF7 G2M CHECKPOINT 0.79 Proportion of DE Features | |
| MCF7 APOPTOSIS 0.30864197530864196 Proportion of DE Features | |
| MCF7 NOTCH SIGNALING 0.3939393939393939 Proportion of DE Features | |
| MCF7 ADIPOGENESIS 0.36 Proportion of DE Features | |
| MCF7 ESTROGEN RESPONSE EARLY 0.575 Proportion of DE Features | |
| MCF7 ESTROGEN RESPONSE LATE 0.5 Proportion of DE Features | |
| MCF7 ANDROGEN RESPONSE 0.5392156862745098 Proportion of DE Features | |
| MCF7 MYOGENESIS 0.205 Proportion of DE Features | |
| MCF7 PROTEIN SECRETION 0.5876288659793815 Proportion of DE Features | |
| MCF7 INTERFERON ALPHA RESPONSE 0.30612244897959184 Proportion of DE Features | |
| MCF7 INTERFERON GAMMA RESPONSE 0.285 Proportion of DE Features | |
| MCF7 APICAL JUNCTION 0.27 Proportion of DE Features | |
| MCF7 APICAL SURFACE 0.26666666666666666 Proportion of DE Features | |
| MCF7 HEDGEHOG SIGNALING 0.2972972972972973 Proportion of DE Features | |
| MCF7 COMPLEMENT 0.225 Proportion of DE Features | |
| MCF7 UNFOLDED PROTEIN RESPONSE 0.5 Proportion of DE Features | |
| MCF7 PI3K AKT MTOR SIGNALING 0.39622641509433965 Proportion of DE Features | |
| MCF7 MTORC1 SIGNALING 0.565 Proportion of DE Features | |
| MCF7 E2F TARGETS 0.83 Proportion of DE Features | |
| MCF7 MYC TARGETS V1 0.81 Proportion of DE Features | |
| MCF7 MYC TARGETS V2 0.559322033898305 Proportion of DE Features | |
| MCF7 EPITHELIAL MESENCHYMAL TRANSITION 0.2 Proportion of DE Features | |
| MCF7 INFLAMMATORY RESPONSE 0.21 Proportion of DE Features | |
| MCF7 XENOBIOTIC METABOLISM 0.29 Proportion of DE Features | |
| MCF7 FATTY ACID METABOLISM 0.3584905660377358 Proportion of DE Features | |
| MCF7 OXIDATIVE PHOSPHORYLATION 0.485 Proportion of DE Features | |
| MCF7 GLYCOLYSIS 0.39 Proportion of DE Features | |
| MCF7 REACTIVE OXYGEN SPECIES PATHWAY 0.36 Proportion of DE Features | |
| MCF7 P53 PATHWAY 0.385 Proportion of DE Features | |
| MCF7 UV RESPONSE UP 0.3333333333333333 Proportion of DE Features | |
| MCF7 UV RESPONSE DN 0.47586206896551725 Proportion of DE Features | |
| MCF7 ANGIOGENESIS 0.21621621621621623 Proportion of DE Features | |
| MCF7 HEME METABOLISM 0.34 Proportion of DE Features | |
| MCF7 COAGULATION 0.17985611510791366 Proportion of DE Features | |
| MCF7 IL2 STAT5 SIGNALING 0.27 Proportion of DE Features | |
| MCF7 BILE ACID METABOLISM 0.2920353982300885 Proportion of DE Features | |
| MCF7 PEROXISOME 0.4857142857142857 Proportion of DE Features | |
| MCF7 ALLOGRAFT REJECTION 0.18 Proportion of DE Features | |
| MCF7 SPERMATOGENESIS 0.21323529411764705 Proportion of DE Features | |
| MCF7 KRAS SIGNALING UP 0.16 Proportion of DE Features | |
| MCF7 KRAS SIGNALING DN 0.15 Proportion of DE Features | |
| MCF7 PANCREAS BETA CELLS 0.07317073170731707 Proportion of DE Features | |
| MCF7 ADIPOGENESIS 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 ALLOGRAFT REJECTION 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 ANDROGEN RESPONSE 3.188327506901682 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 ANGIOGENESIS 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 APICAL JUNCTION 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 APICAL SURFACE 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 APOPTOSIS 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 BILE ACID METABOLISM 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 CHOLESTEROL HOMEOSTASIS 1.2023538580385025 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 COAGULATION 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 COMPLEMENT 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 DNA REPAIR 0.2230299663338629 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 E2F TARGETS 42.17444648823122 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 EPITHELIAL MESENCHYMAL TRANSITION 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 ESTROGEN RESPONSE EARLY 8.78578667545681 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 ESTROGEN RESPONSE LATE 3.887998382414502 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 FATTY ACID METABOLISM 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 G2M CHECKPOINT 35.28720050803406 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 GLYCOLYSIS 0.2407273309715456 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 HEDGEHOG SIGNALING 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 HEME METABOLISM 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 HYPOXIA 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 IL2 STAT5 SIGNALING 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 IL6 JAK STAT3 SIGNALING 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 INFLAMMATORY RESPONSE 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 INTERFERON ALPHA RESPONSE 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 INTERFERON GAMMA RESPONSE 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 KRAS SIGNALING DN 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 KRAS SIGNALING UP 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 MITOTIC SPINDLE 13.730297059360938 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 MTORC1 SIGNALING 8.06842366278414 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 MYC TARGETS V1 38.678106059488464 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 MYC TARGETS V2 2.284425621561431 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 MYOGENESIS 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 NOTCH SIGNALING 0.0206755849602849 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 OXIDATIVE PHOSPHORYLATION 3.188327506901682 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 P53 PATHWAY 0.2230299663338629 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 PANCREAS BETA CELLS 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 PEROXISOME 1.8001663614023942 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 PI3K AKT MTOR SIGNALING 0.2230299663338629 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 PROTEIN SECRETION 4.665012547385346 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 REACTIVE OXYGEN SPECIES PATHWAY 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 SPERMATOGENESIS 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 TGF BETA SIGNALING 1.9098595566790963 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 TNFA SIGNALING VIA NFKB 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 UNFOLDED PROTEIN RESPONSE 2.284425621561431 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 UV RESPONSE DN 2.073464193230864 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 UV RESPONSE UP 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 WNT BETA CATENIN SIGNALING 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| MCF7 XENOBIOTIC METABOLISM 1.9929755751302508e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D ADIPOGENESIS 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D ALLOGRAFT REJECTION 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D ANDROGEN RESPONSE 0.8253802414309696 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D ANGIOGENESIS 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D APICAL JUNCTION 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D APICAL SURFACE 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D APOPTOSIS 0.0998501924105311 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D BILE ACID METABOLISM 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D CHOLESTEROL HOMEOSTASIS 0.2305537328154856 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D COAGULATION 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D COMPLEMENT 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D DNA REPAIR 0.9103706711738552 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D E2F TARGETS 39.43248549964683 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D EPITHELIAL MESENCHYMAL TRANSITION 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D ESTROGEN RESPONSE EARLY 13.7851458900009 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D ESTROGEN RESPONSE LATE 8.571859393417439 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D FATTY ACID METABOLISM 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D G2M CHECKPOINT 39.43248549964683 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D GLYCOLYSIS 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D HEDGEHOG SIGNALING 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D HEME METABOLISM 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D HYPOXIA 0.0998501924105311 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D IL2 STAT5 SIGNALING 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D IL6 JAK STAT3 SIGNALING 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D INFLAMMATORY RESPONSE 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D INTERFERON ALPHA RESPONSE 2.110544332899647 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D INTERFERON GAMMA RESPONSE 1.0099118939315803 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D KRAS SIGNALING DN 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D KRAS SIGNALING UP 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D MITOTIC SPINDLE 10.988308436090303 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D MTORC1 SIGNALING 9.322755335939563 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D MYC TARGETS V1 31.085843680893475 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D MYC TARGETS V2 3.014398088454654 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D MYOGENESIS 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D NOTCH SIGNALING 0.011599289448519 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D OXIDATIVE PHOSPHORYLATION 0.011599289448519 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D P53 PATHWAY 1.0099118939315803 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D PANCREAS BETA CELLS 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D PEROXISOME 0.4981951981065391 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D PI3K AKT MTOR SIGNALING 0.2305537328154856 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D PROTEIN SECRETION 1.2843484597328438 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D REACTIVE OXYGEN SPECIES PATHWAY 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D SPERMATOGENESIS 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D TGF BETA SIGNALING 1.0099118939315803 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D TNFA SIGNALING VIA NFKB 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D UNFOLDED PROTEIN RESPONSE 2.0196866352653005 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D UV RESPONSE DN 1.7548476383464544 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D UV RESPONSE UP 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D WNT BETA CATENIN SIGNALING 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| T47D XENOBIOTIC METABOLISM 1.7357894397959206e-15 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma ADIPOGENESIS 0.6055850088127804 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma ALLOGRAFT REJECTION 2.43843015344394 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma ANDROGEN RESPONSE 1.2361080227963366 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma ANGIOGENESIS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma APICAL JUNCTION -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma APICAL SURFACE -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma APOPTOSIS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma BILE ACID METABOLISM -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma CHOLESTEROL HOMEOSTASIS 0.0792801247498524 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma COAGULATION -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma COMPLEMENT -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma DNA REPAIR 6.904894555900362 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma E2F TARGETS 8.767802822962928 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma EPITHELIAL MESENCHYMAL TRANSITION -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma ESTROGEN RESPONSE EARLY -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma ESTROGEN RESPONSE LATE -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma FATTY ACID METABOLISM 0.1925703545866515 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma G2M CHECKPOINT 9.894795747027056 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma GLYCOLYSIS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma HEDGEHOG SIGNALING -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma HEME METABOLISM 0.0122777732753465 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma HYPOXIA -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma IL2 STAT5 SIGNALING -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma IL6 JAK STAT3 SIGNALING -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma INFLAMMATORY RESPONSE -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma INTERFERON ALPHA RESPONSE 0.7307971049934627 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma INTERFERON GAMMA RESPONSE 2.856608582968025 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma KRAS SIGNALING DN -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma KRAS SIGNALING UP -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma MITOTIC SPINDLE 8.483925857890485 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma MTORC1 SIGNALING 9.55736644573921 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma MYC TARGETS V1 23.85252645207397 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma MYC TARGETS V2 3.0519660303136207 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma MYOGENESIS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma NOTCH SIGNALING -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma OXIDATIVE PHOSPHORYLATION 17.550137632686027 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma P53 PATHWAY -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma PANCREAS BETA CELLS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma PEROXISOME 1.2638962746985 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma PI3K AKT MTOR SIGNALING 5.115148907420571 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma PROTEIN SECRETION 8.767802822962928 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma REACTIVE OXYGEN SPECIES PATHWAY 1.4076707248751592 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma SPERMATOGENESIS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma TGF BETA SIGNALING 0.4947277708064418 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma TNFA SIGNALING VIA NFKB -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma UNFOLDED PROTEIN RESPONSE 4.287234678013019 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma UV RESPONSE DN -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma UV RESPONSE UP -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma WNT BETA CATENIN SIGNALING -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| lymphoma XENOBIOTIC METABOLISM -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna ADIPOGENESIS 0.9573708996682074 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna ALLOGRAFT REJECTION 3.2206126564332824e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna ANDROGEN RESPONSE 9.61354726744481 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna ANGIOGENESIS 3.2206126564332824e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna APICAL JUNCTION 1.4979688306103327 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna APICAL SURFACE 0.5072655538418516 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna APOPTOSIS 5.322983983542562 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna BILE ACID METABOLISM 3.2206126564332824e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna CHOLESTEROL HOMEOSTASIS 3.086284980171764 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna COAGULATION 0.0551760288684452 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna COMPLEMENT 0.7642956391182577 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna DNA REPAIR 0.2232517806678487 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna E2F TARGETS 3.2206126564332824e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna EPITHELIAL MESENCHYMAL TRANSITION 0.0098173358481403 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna ESTROGEN RESPONSE EARLY 3.6096892304896695 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna ESTROGEN RESPONSE LATE 1.227056372863888 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna FATTY ACID METABOLISM 0.3617514202428015 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna G2M CHECKPOINT 3.2206126564332824e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna GLYCOLYSIS 0.5248783762251423 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna HEDGEHOG SIGNALING 0.0098173358481403 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna HEME METABOLISM 0.7050966231902982 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna HYPOXIA 3.6096892304896695 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna IL2 STAT5 SIGNALING 0.4773239407055778 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna IL6 JAK STAT3 SIGNALING 0.1828630112867094 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna INFLAMMATORY RESPONSE 0.0014323690192448 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna INTERFERON ALPHA RESPONSE 2.6882978171991327 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna INTERFERON GAMMA RESPONSE 1.9869603563737828 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna KRAS SIGNALING DN 3.2206126564332824e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna KRAS SIGNALING UP 3.2206126564332824e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna MITOTIC SPINDLE 0.7050966231902982 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna MTORC1 SIGNALING 2.767539367224204 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna MYC TARGETS V1 0.7050966231902982 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna MYC TARGETS V2 3.2206126564332824e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna MYOGENESIS 3.2206126564332824e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna NOTCH SIGNALING 0.4795342089102892 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna OXIDATIVE PHOSPHORYLATION 0.846359756324075 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna P53 PATHWAY 5.123328300162577 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna PANCREAS BETA CELLS 3.2206126564332824e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna PEROXISOME 1.234988525771856 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna PI3K AKT MTOR SIGNALING 0.202959025861837 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna PROTEIN SECRETION 7.885677328003024 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna REACTIVE OXYGEN SPECIES PATHWAY 0.8130537213327431 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna SPERMATOGENESIS 3.2206126564332824e-12 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna TGF BETA SIGNALING 3.224240232894033 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna TNFA SIGNALING VIA NFKB 4.014107431796542 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna UNFOLDED PROTEIN RESPONSE 0.4471742925081833 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna UV RESPONSE DN 1.509234483952229 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna UV RESPONSE UP 0.6985506488884139 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna WNT BETA CATENIN SIGNALING 0.3604458578917283 Gene Set Enrichment (-log10(adjusted p-value)) | |
| prostate_rna XENOBIOTIC METABOLISM 0.1435502919220612 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD ADIPOGENESIS 7.519901304929367 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD ALLOGRAFT REJECTION 0.0932747603470067 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD ANDROGEN RESPONSE 2.2957620038625546 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD ANGIOGENESIS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD APICAL JUNCTION 0.2050895862187817 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD APICAL SURFACE -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD APOPTOSIS 1.263534842520636 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD BILE ACID METABOLISM -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD CHOLESTEROL HOMEOSTASIS 2.4676958831942315 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD COAGULATION 0.2601652193655797 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD COMPLEMENT 0.94260348774318 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD DNA REPAIR 1.864066511159463 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD E2F TARGETS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD EPITHELIAL MESENCHYMAL TRANSITION -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD ESTROGEN RESPONSE EARLY 2.827212697407284 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD ESTROGEN RESPONSE LATE 2.286754097795763 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD FATTY ACID METABOLISM 1.552473827973263 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD G2M CHECKPOINT -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD GLYCOLYSIS 0.94260348774318 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD HEDGEHOG SIGNALING -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD HEME METABOLISM 0.0479099060181349 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD HYPOXIA 0.94260348774318 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD IL2 STAT5 SIGNALING 2.973243017682063 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD IL6 JAK STAT3 SIGNALING 0.0479099060181349 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD INFLAMMATORY RESPONSE 0.2584888118464177 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD INTERFERON ALPHA RESPONSE 0.1731248237076192 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD INTERFERON GAMMA RESPONSE 0.4388417758657348 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD KRAS SIGNALING DN -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD KRAS SIGNALING UP 0.517279549746774 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD MITOTIC SPINDLE 0.061989904305685 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD MTORC1 SIGNALING 8.654971201897736 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD MYC TARGETS V1 14.32144746792644 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD MYC TARGETS V2 -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD MYOGENESIS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD NOTCH SIGNALING 0.1910843317461732 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD OXIDATIVE PHOSPHORYLATION 10.81540724970234 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD P53 PATHWAY 3.1677375281381392 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD PANCREAS BETA CELLS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD PEROXISOME 0.1273563619311295 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD PI3K AKT MTOR SIGNALING 0.3382267543362625 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD PROTEIN SECRETION 6.65113084012504 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD REACTIVE OXYGEN SPECIES PATHWAY 2.827212697407284 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD SPERMATOGENESIS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD TGF BETA SIGNALING 2.0524925392585858 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD TNFA SIGNALING VIA NFKB 6.173002135949128 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD UNFOLDED PROTEIN RESPONSE 2.286754097795763 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD UV RESPONSE DN -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD UV RESPONSE UP 0.7056508328657454 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD WNT BETA CATENIN SIGNALING 0.0366881072122069 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD XENOBIOTIC METABOLISM 0.3016935989075169 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC ADIPOGENESIS 0.6818333123725083 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC ALLOGRAFT REJECTION 6.334845957036903 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC ANDROGEN RESPONSE 1.1871278185047531 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC ANGIOGENESIS 0.7617624485324019 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC APICAL JUNCTION 0.1725853292247004 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC APICAL SURFACE 0.1725853292247004 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC APOPTOSIS 2.1398667532825737 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC BILE ACID METABOLISM -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC CHOLESTEROL HOMEOSTASIS 1.9249314802329391 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC COAGULATION -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC COMPLEMENT 2.3926454917188424 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC DNA REPAIR 0.1725853292247004 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC E2F TARGETS 0.1725853292247004 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC EPITHELIAL MESENCHYMAL TRANSITION 0.5377577854671329 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC ESTROGEN RESPONSE EARLY 0.5377577854671329 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC ESTROGEN RESPONSE LATE 1.2789014350256636 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC FATTY ACID METABOLISM 1.0867929599330328 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC G2M CHECKPOINT -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC GLYCOLYSIS 0.7617624485324019 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC HEDGEHOG SIGNALING -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC HEME METABOLISM -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC HYPOXIA 2.748575280433156 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC IL2 STAT5 SIGNALING 2.053133299418255 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC IL6 JAK STAT3 SIGNALING 2.003295422769558 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC INFLAMMATORY RESPONSE 3.699600064975815 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC INTERFERON ALPHA RESPONSE 0.5862034742964104 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC INTERFERON GAMMA RESPONSE 4.480634319206201 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC KRAS SIGNALING DN -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC KRAS SIGNALING UP 0.7617624485324019 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC MITOTIC SPINDLE -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC MTORC1 SIGNALING 13.870547880808395 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC MYC TARGETS V1 22.92178962028155 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC MYC TARGETS V2 1.1545368583841098 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC MYOGENESIS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC NOTCH SIGNALING 0.0399574392742316 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC OXIDATIVE PHOSPHORYLATION 6.334845957036903 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC P53 PATHWAY 1.585445185865139 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC PANCREAS BETA CELLS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC PEROXISOME -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC PI3K AKT MTOR SIGNALING 0.7680736551795613 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC PROTEIN SECRETION 0.1725853292247004 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC REACTIVE OXYGEN SPECIES PATHWAY 2.581296011942328 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC SPERMATOGENESIS -0.0 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC TGF BETA SIGNALING 0.43517659478475 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC TNFA SIGNALING VIA NFKB 20.59256434213497 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC UNFOLDED PROTEIN RESPONSE 1.1884368408172106 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC UV RESPONSE DN 0.0399574392742316 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC UV RESPONSE UP 0.5582586745997754 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC WNT BETA CATENIN SIGNALING 0.0232861164994045 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUSC XENOBIOTIC METABOLISM 0.6818333123725083 Gene Set Enrichment (-log10(adjusted p-value)) | |
| LUAD ADIPOGENESIS 98.0 scMKL Selection Frequency | |
| LUAD ALLOGRAFT REJECTION 181.0 scMKL Selection Frequency | |
| LUAD ANDROGEN RESPONSE 432.0 scMKL Selection Frequency | |
| LUAD ANGIOGENESIS 92.0 scMKL Selection Frequency | |
| LUAD APICAL JUNCTION 384.0 scMKL Selection Frequency | |
| LUAD APICAL SURFACE 103.0 scMKL Selection Frequency | |
| LUAD APOPTOSIS 213.0 scMKL Selection Frequency | |
| LUAD BILE ACID METABOLISM 88.0 scMKL Selection Frequency | |
| LUAD CHOLESTEROL HOMEOSTASIS 272.0 scMKL Selection Frequency | |
| LUAD COAGULATION 531.0 scMKL Selection Frequency | |
| LUAD COMPLEMENT 162.0 scMKL Selection Frequency | |
| LUAD DNA REPAIR 0.0 scMKL Selection Frequency | |
| LUAD E2F TARGETS 12.0 scMKL Selection Frequency | |
| LUAD EPITHELIAL MESENCHYMAL TRANSITION 246.0 scMKL Selection Frequency | |
| LUAD ESTROGEN RESPONSE EARLY 822.0 scMKL Selection Frequency | |
| LUAD ESTROGEN RESPONSE LATE 984.0 scMKL Selection Frequency | |
| LUAD FATTY ACID METABOLISM 100.0 scMKL Selection Frequency | |
| LUAD G2M CHECKPOINT 28.0 scMKL Selection Frequency | |
| LUAD GLYCOLYSIS 265.0 scMKL Selection Frequency | |
| LUAD HEDGEHOG SIGNALING 31.0 scMKL Selection Frequency | |
| LUAD HEME METABOLISM 98.0 scMKL Selection Frequency | |
| LUAD HYPOXIA 242.0 scMKL Selection Frequency | |
| LUAD IL2 STAT5 SIGNALING 181.0 scMKL Selection Frequency | |
| LUAD IL6 JAK STAT3 SIGNALING 122.0 scMKL Selection Frequency | |
| LUAD INFLAMMATORY RESPONSE 165.0 scMKL Selection Frequency | |
| LUAD INTERFERON ALPHA RESPONSE 111.0 scMKL Selection Frequency | |
| LUAD INTERFERON GAMMA RESPONSE 113.0 scMKL Selection Frequency | |
| LUAD KRAS SIGNALING DN 64.0 scMKL Selection Frequency | |
| LUAD KRAS SIGNALING UP 428.0 scMKL Selection Frequency | |
| LUAD MITOTIC SPINDLE 66.0 scMKL Selection Frequency | |
| LUAD MTORC1 SIGNALING 25.0 scMKL Selection Frequency | |
| LUAD MYC TARGETS V1 4.0 scMKL Selection Frequency | |
| LUAD MYC TARGETS V2 0.0 scMKL Selection Frequency | |
| LUAD MYOGENESIS 109.0 scMKL Selection Frequency | |
| LUAD NOTCH SIGNALING 97.0 scMKL Selection Frequency | |
| LUAD OXIDATIVE PHOSPHORYLATION 72.0 scMKL Selection Frequency | |
| LUAD P53 PATHWAY 133.0 scMKL Selection Frequency | |
| LUAD PANCREAS BETA CELLS 287.0 scMKL Selection Frequency | |
| LUAD PEROXISOME 52.0 scMKL Selection Frequency | |
| LUAD PI3K AKT MTOR SIGNALING 47.0 scMKL Selection Frequency | |
| LUAD PROTEIN SECRETION 175.0 scMKL Selection Frequency | |
| LUAD REACTIVE OXYGEN SPECIES PATHWAY 321.0 scMKL Selection Frequency | |
| LUAD SPERMATOGENESIS 0.0 scMKL Selection Frequency | |
| LUAD TGF BETA SIGNALING 190.0 scMKL Selection Frequency | |
| LUAD TNFA SIGNALING VIA NFKB 414.0 scMKL Selection Frequency | |
| LUAD UNFOLDED PROTEIN RESPONSE 21.0 scMKL Selection Frequency | |
| LUAD UV RESPONSE DN 124.0 scMKL Selection Frequency | |
| LUAD UV RESPONSE UP 152.0 scMKL Selection Frequency | |
| LUAD WNT BETA CATENIN SIGNALING 0.0 scMKL Selection Frequency | |
| LUAD XENOBIOTIC METABOLISM 135.0 scMKL Selection Frequency | |
| LUSC ADIPOGENESIS 101.0 scMKL Selection Frequency | |
| LUSC ALLOGRAFT REJECTION 744.0 scMKL Selection Frequency | |
| LUSC ANDROGEN RESPONSE 278.0 scMKL Selection Frequency | |
| LUSC ANGIOGENESIS 174.0 scMKL Selection Frequency | |
| LUSC APICAL JUNCTION 302.0 scMKL Selection Frequency | |
| LUSC APICAL SURFACE 263.0 scMKL Selection Frequency | |
| LUSC APOPTOSIS 170.0 scMKL Selection Frequency | |
| LUSC BILE ACID METABOLISM 99.0 scMKL Selection Frequency | |
| LUSC CHOLESTEROL HOMEOSTASIS 253.0 scMKL Selection Frequency | |
| LUSC COAGULATION 107.0 scMKL Selection Frequency | |
| LUSC COMPLEMENT 160.0 scMKL Selection Frequency | |
| LUSC DNA REPAIR 100.0 scMKL Selection Frequency | |
| LUSC E2F TARGETS 104.0 scMKL Selection Frequency | |
| LUSC EPITHELIAL MESENCHYMAL TRANSITION 523.0 scMKL Selection Frequency | |
| LUSC ESTROGEN RESPONSE EARLY 327.0 scMKL Selection Frequency | |
| LUSC ESTROGEN RESPONSE LATE 777.0 scMKL Selection Frequency | |
| LUSC FATTY ACID METABOLISM 269.0 scMKL Selection Frequency | |
| LUSC G2M CHECKPOINT 100.0 scMKL Selection Frequency | |
| LUSC GLYCOLYSIS 237.0 scMKL Selection Frequency | |
| LUSC HEDGEHOG SIGNALING 99.0 scMKL Selection Frequency | |
| LUSC HEME METABOLISM 103.0 scMKL Selection Frequency | |
| LUSC HYPOXIA 535.0 scMKL Selection Frequency | |
| LUSC IL2 STAT5 SIGNALING 162.0 scMKL Selection Frequency | |
| LUSC IL6 JAK STAT3 SIGNALING 256.0 scMKL Selection Frequency | |
| LUSC INFLAMMATORY RESPONSE 163.0 scMKL Selection Frequency | |
| LUSC INTERFERON ALPHA RESPONSE 183.0 scMKL Selection Frequency | |
| LUSC INTERFERON GAMMA RESPONSE 294.0 scMKL Selection Frequency | |
| LUSC KRAS SIGNALING DN 101.0 scMKL Selection Frequency | |
| LUSC KRAS SIGNALING UP 234.0 scMKL Selection Frequency | |
| LUSC MITOTIC SPINDLE 100.0 scMKL Selection Frequency | |
| LUSC MTORC1 SIGNALING 313.0 scMKL Selection Frequency | |
| LUSC MYC TARGETS V1 295.0 scMKL Selection Frequency | |
| LUSC MYC TARGETS V2 109.0 scMKL Selection Frequency | |
| LUSC MYOGENESIS 114.0 scMKL Selection Frequency | |
| LUSC NOTCH SIGNALING 100.0 scMKL Selection Frequency | |
| LUSC OXIDATIVE PHOSPHORYLATION 162.0 scMKL Selection Frequency | |
| LUSC P53 PATHWAY 407.0 scMKL Selection Frequency | |
| LUSC PANCREAS BETA CELLS 100.0 scMKL Selection Frequency | |
| LUSC PEROXISOME 101.0 scMKL Selection Frequency | |
| LUSC PI3K AKT MTOR SIGNALING 127.0 scMKL Selection Frequency | |
| LUSC PROTEIN SECRETION 216.0 scMKL Selection Frequency | |
| LUSC REACTIVE OXYGEN SPECIES PATHWAY 1000.0 scMKL Selection Frequency | |
| LUSC SPERMATOGENESIS 100.0 scMKL Selection Frequency | |
| LUSC TGF BETA SIGNALING 178.0 scMKL Selection Frequency | |
| LUSC TNFA SIGNALING VIA NFKB 783.0 scMKL Selection Frequency | |
| LUSC UNFOLDED PROTEIN RESPONSE 104.0 scMKL Selection Frequency | |
| LUSC UV RESPONSE DN 100.0 scMKL Selection Frequency | |
| LUSC UV RESPONSE UP 150.0 scMKL Selection Frequency | |
| LUSC WNT BETA CATENIN SIGNALING 100.0 scMKL Selection Frequency | |
| LUSC XENOBIOTIC METABOLISM 355.0 scMKL Selection Frequency | |
| MCF7 ADIPOGENESIS 118.0 scMKL Selection Frequency | |
| MCF7 ALLOGRAFT REJECTION 100.0 scMKL Selection Frequency | |
| MCF7 ANDROGEN RESPONSE 527.0 scMKL Selection Frequency | |
| MCF7 ANGIOGENESIS 90.0 scMKL Selection Frequency | |
| MCF7 APICAL JUNCTION 100.0 scMKL Selection Frequency | |
| MCF7 APICAL SURFACE 406.0 scMKL Selection Frequency | |
| MCF7 APOPTOSIS 158.0 scMKL Selection Frequency | |
| MCF7 BILE ACID METABOLISM 149.0 scMKL Selection Frequency | |
| MCF7 CHOLESTEROL HOMEOSTASIS 452.0 scMKL Selection Frequency | |
| MCF7 COAGULATION 102.0 scMKL Selection Frequency | |
| MCF7 COMPLEMENT 100.0 scMKL Selection Frequency | |
| MCF7 DNA REPAIR 100.0 scMKL Selection Frequency | |
| MCF7 E2F TARGETS 567.0 scMKL Selection Frequency | |
| MCF7 EPITHELIAL MESENCHYMAL TRANSITION 110.0 scMKL Selection Frequency | |
| MCF7 ESTROGEN RESPONSE EARLY 992.0 scMKL Selection Frequency | |
| MCF7 ESTROGEN RESPONSE LATE 686.0 scMKL Selection Frequency | |
| MCF7 FATTY ACID METABOLISM 120.0 scMKL Selection Frequency | |
| MCF7 G2M CHECKPOINT 847.0 scMKL Selection Frequency | |
| MCF7 GLYCOLYSIS 159.0 scMKL Selection Frequency | |
| MCF7 HEDGEHOG SIGNALING 164.0 scMKL Selection Frequency | |
| MCF7 HEME METABOLISM 140.0 scMKL Selection Frequency | |
| MCF7 HYPOXIA 191.0 scMKL Selection Frequency | |
| MCF7 IL2 STAT5 SIGNALING 105.0 scMKL Selection Frequency | |
| MCF7 IL6 JAK STAT3 SIGNALING 172.0 scMKL Selection Frequency | |
| MCF7 INFLAMMATORY RESPONSE 134.0 scMKL Selection Frequency | |
| MCF7 INTERFERON ALPHA RESPONSE 187.0 scMKL Selection Frequency | |
| MCF7 INTERFERON GAMMA RESPONSE 101.0 scMKL Selection Frequency | |
| MCF7 KRAS SIGNALING DN 100.0 scMKL Selection Frequency | |
| MCF7 KRAS SIGNALING UP 121.0 scMKL Selection Frequency | |
| MCF7 MITOTIC SPINDLE 192.0 scMKL Selection Frequency | |
| MCF7 MTORC1 SIGNALING 165.0 scMKL Selection Frequency | |
| MCF7 MYC TARGETS V1 211.0 scMKL Selection Frequency | |
| MCF7 MYC TARGETS V2 199.0 scMKL Selection Frequency | |
| MCF7 MYOGENESIS 160.0 scMKL Selection Frequency | |
| MCF7 NOTCH SIGNALING 286.0 scMKL Selection Frequency | |
| MCF7 OXIDATIVE PHOSPHORYLATION 117.0 scMKL Selection Frequency | |
| MCF7 P53 PATHWAY 202.0 scMKL Selection Frequency | |
| MCF7 PANCREAS BETA CELLS 113.0 scMKL Selection Frequency | |
| MCF7 PEROXISOME 239.0 scMKL Selection Frequency | |
| MCF7 PI3K AKT MTOR SIGNALING 158.0 scMKL Selection Frequency | |
| MCF7 PROTEIN SECRETION 713.0 scMKL Selection Frequency | |
| MCF7 REACTIVE OXYGEN SPECIES PATHWAY 107.0 scMKL Selection Frequency | |
| MCF7 SPERMATOGENESIS 100.0 scMKL Selection Frequency | |
| MCF7 TGF BETA SIGNALING 776.0 scMKL Selection Frequency | |
| MCF7 TNFA SIGNALING VIA NFKB 119.0 scMKL Selection Frequency | |
| MCF7 UNFOLDED PROTEIN RESPONSE 175.0 scMKL Selection Frequency | |
| MCF7 UV RESPONSE DN 753.0 scMKL Selection Frequency | |
| MCF7 UV RESPONSE UP 124.0 scMKL Selection Frequency | |
| MCF7 WNT BETA CATENIN SIGNALING 101.0 scMKL Selection Frequency | |
| MCF7 XENOBIOTIC METABOLISM 232.0 scMKL Selection Frequency | |
| T47D ADIPOGENESIS 103.0 scMKL Selection Frequency | |
| T47D ALLOGRAFT REJECTION 100.0 scMKL Selection Frequency | |
| T47D ANDROGEN RESPONSE 291.0 scMKL Selection Frequency | |
| T47D ANGIOGENESIS 103.0 scMKL Selection Frequency | |
| T47D APICAL JUNCTION 171.0 scMKL Selection Frequency | |
| T47D APICAL SURFACE 308.0 scMKL Selection Frequency | |
| T47D APOPTOSIS 137.0 scMKL Selection Frequency | |
| T47D BILE ACID METABOLISM 130.0 scMKL Selection Frequency | |
| T47D CHOLESTEROL HOMEOSTASIS 512.0 scMKL Selection Frequency | |
| T47D COAGULATION 117.0 scMKL Selection Frequency | |
| T47D COMPLEMENT 104.0 scMKL Selection Frequency | |
| T47D DNA REPAIR 107.0 scMKL Selection Frequency | |
| T47D E2F TARGETS 347.0 scMKL Selection Frequency | |
| T47D EPITHELIAL MESENCHYMAL TRANSITION 142.0 scMKL Selection Frequency | |
| T47D ESTROGEN RESPONSE EARLY 986.0 scMKL Selection Frequency | |
| T47D ESTROGEN RESPONSE LATE 776.0 scMKL Selection Frequency | |
| T47D FATTY ACID METABOLISM 206.0 scMKL Selection Frequency | |
| T47D G2M CHECKPOINT 338.0 scMKL Selection Frequency | |
| T47D GLYCOLYSIS 120.0 scMKL Selection Frequency | |
| T47D HEDGEHOG SIGNALING 837.0 scMKL Selection Frequency | |
| T47D HEME METABOLISM 220.0 scMKL Selection Frequency | |
| T47D HYPOXIA 416.0 scMKL Selection Frequency | |
| T47D IL2 STAT5 SIGNALING 108.0 scMKL Selection Frequency | |
| T47D IL6 JAK STAT3 SIGNALING 188.0 scMKL Selection Frequency | |
| T47D INFLAMMATORY RESPONSE 137.0 scMKL Selection Frequency | |
| T47D INTERFERON ALPHA RESPONSE 422.0 scMKL Selection Frequency | |
| T47D INTERFERON GAMMA RESPONSE 173.0 scMKL Selection Frequency | |
| T47D KRAS SIGNALING DN 100.0 scMKL Selection Frequency | |
| T47D KRAS SIGNALING UP 118.0 scMKL Selection Frequency | |
| T47D MITOTIC SPINDLE 175.0 scMKL Selection Frequency | |
| T47D MTORC1 SIGNALING 186.0 scMKL Selection Frequency | |
| T47D MYC TARGETS V1 116.0 scMKL Selection Frequency | |
| T47D MYC TARGETS V2 116.0 scMKL Selection Frequency | |
| T47D MYOGENESIS 184.0 scMKL Selection Frequency | |
| T47D NOTCH SIGNALING 174.0 scMKL Selection Frequency | |
| T47D OXIDATIVE PHOSPHORYLATION 113.0 scMKL Selection Frequency | |
| T47D P53 PATHWAY 326.0 scMKL Selection Frequency | |
| T47D PANCREAS BETA CELLS 113.0 scMKL Selection Frequency | |
| T47D PEROXISOME 234.0 scMKL Selection Frequency | |
| T47D PI3K AKT MTOR SIGNALING 157.0 scMKL Selection Frequency | |
| T47D PROTEIN SECRETION 272.0 scMKL Selection Frequency | |
| T47D REACTIVE OXYGEN SPECIES PATHWAY 198.0 scMKL Selection Frequency | |
| T47D SPERMATOGENESIS 100.0 scMKL Selection Frequency | |
| T47D TGF BETA SIGNALING 874.0 scMKL Selection Frequency | |
| T47D TNFA SIGNALING VIA NFKB 411.0 scMKL Selection Frequency | |
| T47D UNFOLDED PROTEIN RESPONSE 101.0 scMKL Selection Frequency | |
| T47D UV RESPONSE DN 696.0 scMKL Selection Frequency | |
| T47D UV RESPONSE UP 103.0 scMKL Selection Frequency | |
| T47D WNT BETA CATENIN SIGNALING 131.0 scMKL Selection Frequency | |
| T47D XENOBIOTIC METABOLISM 201.0 scMKL Selection Frequency | |
| lymphoma ADIPOGENESIS 42.0 scMKL Selection Frequency | |
| lymphoma ALLOGRAFT REJECTION 644.0 scMKL Selection Frequency | |
| lymphoma ANDROGEN RESPONSE 100.0 scMKL Selection Frequency | |
| lymphoma ANGIOGENESIS 41.0 scMKL Selection Frequency | |
| lymphoma APICAL JUNCTION 95.0 scMKL Selection Frequency | |
| lymphoma APICAL SURFACE 208.0 scMKL Selection Frequency | |
| lymphoma APOPTOSIS 32.0 scMKL Selection Frequency | |
| lymphoma BILE ACID METABOLISM 21.0 scMKL Selection Frequency | |
| lymphoma CHOLESTEROL HOMEOSTASIS 16.0 scMKL Selection Frequency | |
| lymphoma COAGULATION 99.0 scMKL Selection Frequency | |
| lymphoma COMPLEMENT 148.0 scMKL Selection Frequency | |
| lymphoma DNA REPAIR 98.0 scMKL Selection Frequency | |
| lymphoma E2F TARGETS 70.0 scMKL Selection Frequency | |
| lymphoma EPITHELIAL MESENCHYMAL TRANSITION 7.0 scMKL Selection Frequency | |
| lymphoma ESTROGEN RESPONSE EARLY 107.0 scMKL Selection Frequency | |
| lymphoma ESTROGEN RESPONSE LATE 37.0 scMKL Selection Frequency | |
| lymphoma FATTY ACID METABOLISM 52.0 scMKL Selection Frequency | |
| lymphoma G2M CHECKPOINT 106.0 scMKL Selection Frequency | |
| lymphoma GLYCOLYSIS 11.0 scMKL Selection Frequency | |
| lymphoma HEDGEHOG SIGNALING 647.0 scMKL Selection Frequency | |
| lymphoma HEME METABOLISM 101.0 scMKL Selection Frequency | |
| lymphoma HYPOXIA 66.0 scMKL Selection Frequency | |
| lymphoma IL2 STAT5 SIGNALING 158.0 scMKL Selection Frequency | |
| lymphoma IL6 JAK STAT3 SIGNALING 247.0 scMKL Selection Frequency | |
| lymphoma INFLAMMATORY RESPONSE 50.0 scMKL Selection Frequency | |
| lymphoma INTERFERON ALPHA RESPONSE 80.0 scMKL Selection Frequency | |
| lymphoma INTERFERON GAMMA RESPONSE 240.0 scMKL Selection Frequency | |
| lymphoma KRAS SIGNALING DN 92.0 scMKL Selection Frequency | |
| lymphoma KRAS SIGNALING UP 108.0 scMKL Selection Frequency | |
| lymphoma MITOTIC SPINDLE 237.0 scMKL Selection Frequency | |
| lymphoma MTORC1 SIGNALING 86.0 scMKL Selection Frequency | |
| lymphoma MYC TARGETS V1 102.0 scMKL Selection Frequency | |
| lymphoma MYC TARGETS V2 76.0 scMKL Selection Frequency | |
| lymphoma MYOGENESIS 100.0 scMKL Selection Frequency | |
| lymphoma NOTCH SIGNALING 283.0 scMKL Selection Frequency | |
| lymphoma OXIDATIVE PHOSPHORYLATION 81.0 scMKL Selection Frequency | |
| lymphoma P53 PATHWAY 98.0 scMKL Selection Frequency | |
| lymphoma PANCREAS BETA CELLS 57.0 scMKL Selection Frequency | |
| lymphoma PEROXISOME 103.0 scMKL Selection Frequency | |
| lymphoma PI3K AKT MTOR SIGNALING 29.0 scMKL Selection Frequency | |
| lymphoma PROTEIN SECRETION 950.0 scMKL Selection Frequency | |
| lymphoma REACTIVE OXYGEN SPECIES PATHWAY 6.0 scMKL Selection Frequency | |
| lymphoma SPERMATOGENESIS 95.0 scMKL Selection Frequency | |
| lymphoma TGF BETA SIGNALING 822.0 scMKL Selection Frequency | |
| lymphoma TNFA SIGNALING VIA NFKB 1.0 scMKL Selection Frequency | |
| lymphoma UNFOLDED PROTEIN RESPONSE 102.0 scMKL Selection Frequency | |
| lymphoma UV RESPONSE DN 341.0 scMKL Selection Frequency | |
| lymphoma UV RESPONSE UP 100.0 scMKL Selection Frequency | |
| lymphoma WNT BETA CATENIN SIGNALING 0.0 scMKL Selection Frequency | |
| lymphoma XENOBIOTIC METABOLISM 0.0 scMKL Selection Frequency | |
| prostate_rna ADIPOGENESIS 114.0 scMKL Selection Frequency | |
| prostate_rna ALLOGRAFT REJECTION 691.0 scMKL Selection Frequency | |
| prostate_rna ANDROGEN RESPONSE 762.0 scMKL Selection Frequency | |
| prostate_rna ANGIOGENESIS 843.0 scMKL Selection Frequency | |
| prostate_rna APICAL JUNCTION 143.0 scMKL Selection Frequency | |
| prostate_rna APICAL SURFACE 865.0 scMKL Selection Frequency | |
| prostate_rna APOPTOSIS 262.0 scMKL Selection Frequency | |
| prostate_rna BILE ACID METABOLISM 187.0 scMKL Selection Frequency | |
| prostate_rna CHOLESTEROL HOMEOSTASIS 551.0 scMKL Selection Frequency | |
| prostate_rna COAGULATION 813.0 scMKL Selection Frequency | |
| prostate_rna COMPLEMENT 344.0 scMKL Selection Frequency | |
| prostate_rna DNA REPAIR 86.0 scMKL Selection Frequency | |
| prostate_rna E2F TARGETS 52.0 scMKL Selection Frequency | |
| prostate_rna EPITHELIAL MESENCHYMAL TRANSITION 444.0 scMKL Selection Frequency | |
| prostate_rna ESTROGEN RESPONSE EARLY 566.0 scMKL Selection Frequency | |
| prostate_rna ESTROGEN RESPONSE LATE 427.0 scMKL Selection Frequency | |
| prostate_rna FATTY ACID METABOLISM 195.0 scMKL Selection Frequency | |
| prostate_rna G2M CHECKPOINT 92.0 scMKL Selection Frequency | |
| prostate_rna GLYCOLYSIS 96.0 scMKL Selection Frequency | |
| prostate_rna HEDGEHOG SIGNALING 476.0 scMKL Selection Frequency | |
| prostate_rna HEME METABOLISM 120.0 scMKL Selection Frequency | |
| prostate_rna HYPOXIA 271.0 scMKL Selection Frequency | |
| prostate_rna IL2 STAT5 SIGNALING 419.0 scMKL Selection Frequency | |
| prostate_rna IL6 JAK STAT3 SIGNALING 105.0 scMKL Selection Frequency | |
| prostate_rna INFLAMMATORY RESPONSE 351.0 scMKL Selection Frequency | |
| prostate_rna INTERFERON ALPHA RESPONSE 169.0 scMKL Selection Frequency | |
| prostate_rna INTERFERON GAMMA RESPONSE 161.0 scMKL Selection Frequency | |
| prostate_rna KRAS SIGNALING DN 137.0 scMKL Selection Frequency | |
| prostate_rna KRAS SIGNALING UP 281.0 scMKL Selection Frequency | |
| prostate_rna MITOTIC SPINDLE 99.0 scMKL Selection Frequency | |
| prostate_rna MTORC1 SIGNALING 147.0 scMKL Selection Frequency | |
| prostate_rna MYC TARGETS V1 334.0 scMKL Selection Frequency | |
| prostate_rna MYC TARGETS V2 176.0 scMKL Selection Frequency | |
| prostate_rna MYOGENESIS 101.0 scMKL Selection Frequency | |
| prostate_rna NOTCH SIGNALING 148.0 scMKL Selection Frequency | |
| prostate_rna OXIDATIVE PHOSPHORYLATION 113.0 scMKL Selection Frequency | |
| prostate_rna P53 PATHWAY 226.0 scMKL Selection Frequency | |
| prostate_rna PANCREAS BETA CELLS 411.0 scMKL Selection Frequency | |
| prostate_rna PEROXISOME 92.0 scMKL Selection Frequency | |
| prostate_rna PI3K AKT MTOR SIGNALING 79.0 scMKL Selection Frequency | |
| prostate_rna PROTEIN SECRETION 172.0 scMKL Selection Frequency | |
| prostate_rna REACTIVE OXYGEN SPECIES PATHWAY 213.0 scMKL Selection Frequency | |
| prostate_rna SPERMATOGENESIS 100.0 scMKL Selection Frequency | |
| prostate_rna TGF BETA SIGNALING 228.0 scMKL Selection Frequency | |
| prostate_rna TNFA SIGNALING VIA NFKB 451.0 scMKL Selection Frequency | |
| prostate_rna UNFOLDED PROTEIN RESPONSE 108.0 scMKL Selection Frequency | |
| prostate_rna UV RESPONSE DN 453.0 scMKL Selection Frequency | |
| prostate_rna UV RESPONSE UP 103.0 scMKL Selection Frequency | |
| prostate_rna WNT BETA CATENIN SIGNALING 83.0 scMKL Selection Frequency | |
| prostate_rna XENOBIOTIC METABOLISM 371.0 scMKL Selection Frequency | |